|
GPN1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.655600E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.111000E-01 |
| Normal-vs-Stage2 |
3.023200E-01 |
| Normal-vs-Stage3 |
2.042200E-02 |
| Normal-vs-Stage4 |
5.338100E-02 |
| Stage1-vs-Stage2 |
6.901800E-01 |
| Stage1-vs-Stage3 |
8.232300E-02 |
| Stage1-vs-Stage4 |
1.902570E-01 |
| Stage2-vs-Stage3 |
4.367400E-01 |
| Stage2-vs-Stage4 |
5.741600E-01 |
| Stage3-vs-Stage4 |
8.030400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.560300E-02 |
| Normal-vs-AfricanAmerican |
1.020060E-03 |
| Normal-vs-Asian |
3.766800E-01 |
| Caucasian-vs-AfricanAmerican |
3.755600E-02 |
| Caucasian-vs-Asian |
2.540600E-01 |
| AfricanAmerican-vs-Asian |
1.376750E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.080300E-02 |
| Normal-vs-Female |
1.405770E-01 |
| Male-vs-Female |
6.142000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.501190E-01 |
| Normal-vs-Age(41-60Yrs) |
2.076100E-02 |
| Normal-vs-Age(61-80Yrs) |
2.180800E-01 |
| Normal-vs-Age(81-100Yrs) |
6.149000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.778200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.864400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.965000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.948830E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.738800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.896600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.406200E-01 |
| Normal-vs-Grade 2 |
2.830200E-01 |
| Normal-vs-Grade 3 |
5.268000E-02 |
| Normal-vs-Grade 4 |
3.068400E-02 |
| Grade 1-vs-Grade 2 |
9.829000E-01 |
| Grade 1-vs-Grade 3 |
6.040600E-01 |
| Grade 1-vs-Grade 4 |
2.811200E-01 |
| Grade 2-vs-Grade 3 |
2.939400E-01 |
| Grade 2-vs-Grade 4 |
1.213970E-01 |
| Grade 3-vs-Grade 4 |
3.376400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.992400E-01 |
| Normal-vs-ccB subtype |
2.038000E-02 |
| ccA subtype-vs-ccB subtype |
4.057900E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.554640E-01 |
| Normal-vs-N1 |
5.899000E-01 |
| N0-vs-N1 |
3.583800E-01 |
|
|
